Heligenics

Heligenics is a life sciences company that has developed technology to display the impact of genetic mutations in order to transform genetic testing and drug development for serious diseases. It measures the significance of mutations in the human genome through a parallel in vitro process called GigaAssay, assessing the effects of all potential amino acid substitutions in functional target proteins, completing in months what would traditionally take years. For cancer diagnostics companies, Heligenics' functional data can enhance the interpretation of genetic tests, while for pharmaceutical companies, it can convert generic drugs into targeted precision medicines or rescue failed drug candidates by redesigning genetically stratified clinical trials to identify variants.